Clearbridge Health Ltd. (SG:1H3) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clearbridge Health Ltd. successfully concluded its renounceable non-underwritten rights issue, with subscriptions reaching approximately 164.8% of the available shares. This strong response indicates robust investor interest and confidence in the company’s future prospects. The new ordinary shares from this rights issue will soon be listed and quoted, potentially impacting the company’s stock performance.
For further insights into SG:1H3 stock, check out TipRanks’ Stock Analysis page.